3,929
Views
5
CrossRef citations to date
0
Altmetric
Hematology

A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A

, , &
Pages 1493-1498 | Received 16 Jun 2020, Accepted 13 Sep 2020, Published online: 16 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Ravichandran Chandrasekaran, Mauro Dávoli, Zulaiha Muda, Uendy Pérez-Lozano, Naouel Salhi, Nakul Saxena, Ming-Ching Shen, HyeRyoung Haylee Song, Darintr Sosothikul, Veronica Soledad Soto-Arellano & Igor Solev. (2023) Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs. BMC Research Notes 16:1.
Crossref
Mohammed Nadimul Islam, Akhil Ranjon Biswas, Humayra Nazneen, Nobendu Chowdhury, Mahbubul Alam, Jayanta Banik, Md. Kamrul Hassan, Abdullah Az Zubayer Khan, Najmul Karim, Mohammad Jahid Hasan & Md. Abdullah Saeed Khan. (2022) Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh. Orphanet Journal of Rare Diseases 17:1.
Crossref
Juan A. De De Pablo-Moreno, Luis Javier Serrano, Luis Revuelta, María José Sánchez & Antonio Liras. (2022) The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V. International Journal of Molecular Sciences 23:15, pages 8283.
Crossref
James E. Frampton. (2021) Efmoroctocog Alfa: A Review in Haemophilia A. Drugs 81:17, pages 2035-2046.
Crossref